85329-89-1

Basic information

• Product Name: (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide phosphate (1:1)
• CAS NO: 85329-89-1
• Molecular Formula: C₂₆H₄₀N₅O₆P
• Molecular Weight: 549.5995
• Mol File: 85329-89-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide phosphate (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide phosphate (1:1)(85329-89-1)
• EPA Substance Registry System: (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide phosphate (1:1)(85329-89-1)

Safety Data

• Hazardous Substances Data: 85329-89-1(Hazardous Substances Data)

Usage

General Description

The chemical (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide phosphate (1:1) is a complex organic compound with a phosphate salt. It has a molecular structure that includes an ergoline core, with two substituents at the N position and a carbamoyl group at the N position, as well as a phosphate group. (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide phosphate (1:1) is likely to have pharmacological properties due to its structure, potentially interacting with biological targets such as receptors or enzymes. Further research and characterization of this chemical are necessary to fully understand its properties and potential applications.

Upstream product

• 56741-94-7 2-amino-6-phenyl-3H-pyrimidin-4-one 
• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 98-88-4 benzoyl chloride 
• 614-27-7 methyl 3-oxo-3-phenylpropionate 
• 93-58-3 benzoic acid methyl ester 
• 1402242-62-9 potassium trifluoro(3-oxo-3-phenylprop-1-yn-1-yl)borate 

Relevant articles and documents

Pyrimidin-6-yl Trifluoroborate Salts as Versatile Templates for Heterocycle Synthesis

We report a novel and general method to access a highly under-studied privileged scaffold—pyrimidines bearing a trifluoroborate at C4, and highlight the broad utility of these intermediates in a rich array of downstream functionalization reactions. This chemistry is underpinned by the unique features of the trifluoroborate group; its robustness provides an opportunity to carry out chemoselective reactions at other positions on the pyrimidine while providing a pathway for elaboration at the C?B bond when suitably activated.

HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase

The identification of novel, non-purine based inhibitors of xanthine oxidase is described. After a high-throughput screening campaign, an NMR based counterscreen was used to distinguish actives, which interact with XO in a reversible manner, from assay artefacts. This approach identified pyrimidone 1 as a reversible and competitive inhibitor with good lead-like properties. A hit to lead campaign gave compound 41, a nanomolar inhibitor of hXO with efficacy in the hyperuricemic rat model after oral dosing.

5-Substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral- and interferon-inducing agents

-